CONMED Corporation (CNMD)

CONMED Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	1,316	1,307	1,245	1,045	1,011	862.46
Revenue Growth (YoY)	4.32%	5.00%	19.06%	3.45%	17.18%	-9.70%
Cost of Revenue	575.38	573.98	559.9	469.73	442.6	402.16
Gross Profit	740.62	733.03	684.85	575.75	568.04	460.3
Selling, General & Admin	534.32	519.33	504.66	441.42	414.73	374.17
Research & Development	53.78	54.43	52.6	47.15	43.57	40.47
Operating Expenses	588.1	573.75	557.26	488.57	458.29	414.65
Operating Income	152.52	159.28	127.58	87.17	109.74	45.66
Interest Expense	-35.99	-37.3	-39.78	-28.91	-35.49	-44.05
Other Non Operating Income (Expenses)	-	-	-	-	-0.05	-
EBT Excluding Unusual Items	116.53	121.98	87.81	58.27	74.21	1.6
Merger & Restructuring Charges	-1.8	-	-9.4	-14.6	-	-
Other Unusual Items	30.55	41.05	2.42	-114.53	-1.1	-
Pretax Income	145.28	163.03	80.83	-70.86	73.11	1.6
Income Tax Expense	26.53	30.61	16.37	9.72	10.56	-7.91
Net Income	118.75	132.42	64.46	-80.58	62.54	9.52
Net Income to Common	118.75	132.42	64.46	-80.58	62.54	9.52
Net Income Growth	44.20%	105.44%	-	-	557.16%	-66.75%
Shares Outstanding (Basic)	31	31	31	30	29	29
Shares Outstanding (Diluted)	31	31	32	30	32	29
Shares Change (YoY)	-1.41%	-1.26%	5.02%	-6.75%	9.34%	-0.10%
EPS (Basic)	3.84	4.29	2.10	-2.68	2.14	0.33
EPS (Diluted)	3.81	4.25	2.04	-2.68	1.94	0.32
EPS Growth	46.38%	108.33%	-	-	506.25%	-67.01%
Free Cash Flow	164.55	153.88	106.32	11.58	96.9	51.52
Free Cash Flow Per Share	5.29	4.94	3.37	0.39	3.01	1.75
Dividend Per Share	0.800	0.800	0.800	0.800	0.800	0.800
Gross Margin	56.28%	56.08%	55.02%	55.07%	56.21%	53.37%
Operating Margin	11.59%	12.19%	10.25%	8.34%	10.86%	5.29%
Profit Margin	9.02%	10.13%	5.18%	-7.71%	6.19%	1.10%
Free Cash Flow Margin	12.50%	11.77%	8.54%	1.11%	9.59%	5.97%
EBITDA	223.2	229.74	197.76	154.59	177.19	113.58
EBITDA Margin	16.96%	17.58%	15.89%	14.79%	17.53%	13.17%
D&A For EBITDA	70.67	70.46	70.17	67.42	67.44	67.93
EBIT	152.52	159.28	127.58	87.17	109.74	45.66
EBIT Margin	11.59%	12.19%	10.25%	8.34%	10.86%	5.29%
Effective Tax Rate	18.26%	18.77%	20.25%	-	14.45%	-

Updated Apr 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q